Cargando…
TP53 mutations, amplification of P63 and expression of cell cycle proteins in squamous cell carcinoma of the oesophagus from a low incidence area in Western Europe
In Europe, high incidence rates of oesophageal squamous cell carcinoma (SCCE) are observed in western France (Normandy and Brittany) and in north-eastern Italy. Analysis of TP53 mutations in tumours from these regions has shown a high prevalence of mutations at A:T basepairs that may result from DNA...
Autores principales: | Tanière, P, Martel-Planche, G, Saurin, J C, Lombard-Bohas, C, Berger, F, Scoazec, J Y, Hainaut, P |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2001
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364124/ https://www.ncbi.nlm.nih.gov/pubmed/11531258 http://dx.doi.org/10.1054/bjoc.2001.1990 |
Ejemplares similares
-
Low Prevalence of TP53 Mutations and MDM2 Amplifications in Pediatric Rhabdomyosarcoma
por: Ognjanovic, Simona, et al.
Publicado: (2012) -
TP53 mutations, human papilloma virus DNA and inflammation markers in esophageal squamous cell carcinoma from the Rift Valley, a high-incidence area in Kenya
por: Patel, Kirtika, et al.
Publicado: (2011) -
The TP53 fertility network
por: Paskulin, Diego d’Avila, et al.
Publicado: (2012) -
Lessons from TP53 mutations in breast cancers: from carcinogen fingerprints to clinical correlates
por: Hainaut, P, et al.
Publicado: (2000) -
TP53 mutation p.R337H in gastric cancer tissues of a 12-year-old male child - evidence for chimerism involving a common mutant founder haplotype: case report
por: da Silva, Edaise M, et al.
Publicado: (2011)